Literature DB >> 19946277

Nongenetic method for purifying stem cell-derived cardiomyocytes.

Fumiyuki Hattori1, Hao Chen, Hiromi Yamashita, Shugo Tohyama, Yu-Suke Satoh, Shinsuke Yuasa, Weizhen Li, Hiroyuki Yamakawa, Tomofumi Tanaka, Takeshi Onitsuka, Kenichiro Shimoji, Yohei Ohno, Toru Egashira, Ruri Kaneda, Mitsushige Murata, Kyoko Hidaka, Takayuki Morisaki, Erika Sasaki, Takeshi Suzuki, Motoaki Sano, Shinji Makino, Shinzo Oikawa, Keiichi Fukuda.   

Abstract

Several applications of pluripotent stem cell (PSC)-derived cardiomyocytes require elimination of undifferentiated cells. A major limitation for cardiomyocyte purification is the lack of easy and specific cell marking techniques. We found that a fluorescent dye that labels mitochondria, tetramethylrhodamine methyl ester perchlorate, could be used to selectively mark embryonic and neonatal rat cardiomyocytes, as well as mouse, marmoset and human PSC-derived cardiomyocytes, and that the cells could subsequently be enriched (>99% purity) by fluorescence-activated cell sorting. Purified cardiomyocytes transplanted into testes did not induce teratoma formation. Moreover, aggregate formation of PSC-derived cardiomyocytes through homophilic cell-cell adhesion improved their survival in the immunodeficient mouse heart. Our approaches will aid in the future success of using PSC-derived cardiomyocytes for basic and clinical applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946277     DOI: 10.1038/nmeth.1403

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  21 in total

1.  Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium.

Authors:  Arnoud C Fijnvandraat; Antoni C G van Ginneken; Cees A Schumacher; Kenneth R Boheler; Ronald H Lekanne Deprez; Vincent M Christoffels; Antoon F M Moorman
Journal:  J Mol Cell Cardiol       Date:  2003-12       Impact factor: 5.000

Review 2.  High resolution imaging of live mitochondria.

Authors:  Stefan Jakobs
Journal:  Biochim Biophys Acta       Date:  2006-04-20

3.  Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.

Authors:  Tomonori Tsukahara; Hideyuki Agawa; Sayori Matsumoto; Mizuho Matsuda; Shuichi Ueno; Yuki Yamashita; Koichiro Yamada; Nobuyuki Tanaka; Katsuhiko Kojima; Toshikazu Takeshita
Journal:  Biochem Biophys Res Commun       Date:  2006-05-08       Impact factor: 3.575

4.  Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.

Authors:  Alessandra Recchia; Chiara Bonini; Zulma Magnani; Fabrizia Urbinati; Daniela Sartori; Sara Muraro; Enrico Tagliafico; Attilio Bondanza; Maria Teresa Lupo Stanghellini; Massimo Bernardi; Alessandra Pescarollo; Fabio Ciceri; Claudio Bordignon; Fulvio Mavilio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

5.  Identification and selection of cardiomyocytes during human embryonic stem cell differentiation.

Authors:  Irit Huber; Ilanit Itzhaki; Oren Caspi; Gil Arbel; Maty Tzukerman; Amira Gepstein; Manhal Habib; Lior Yankelson; Izhak Kehat; Lior Gepstein
Journal:  FASEB J       Date:  2007-04-13       Impact factor: 5.191

6.  Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells.

Authors:  Chunhui Xu; Shailaja Police; Mohammad Hassanipour; Joseph D Gold
Journal:  Stem Cells Dev       Date:  2006-10       Impact factor: 3.272

7.  Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells.

Authors:  Kyoko Hidaka; Jong-Kook Lee; Hoe Suk Kim; Chun Hwa Ihm; Akio Iio; Minetaro Ogawa; Shin-Ichi Nishikawa; Itsuo Kodama; Takayuki Morisaki
Journal:  FASEB J       Date:  2003-02-19       Impact factor: 5.191

8.  Lentiviral vector-mediated gene delivery into human embryonic stem cells.

Authors:  Michal Gropp; Benjamin Reubinoff
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

9.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

10.  Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium.

Authors:  Eugen Kolossov; Toktam Bostani; Wilhelm Roell; Martin Breitbach; Frank Pillekamp; Jens M Nygren; Philipp Sasse; Olga Rubenchik; Jochen W U Fries; Daniela Wenzel; Caroline Geisen; Ying Xia; Zhongju Lu; Yaqi Duan; Ralf Kettenhofen; Stefan Jovinge; Wilhelm Bloch; Heribert Bohlen; Armin Welz; Juergen Hescheler; Sten Eirik Jacobsen; Bernd K Fleischmann
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

View more
  157 in total

1.  Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells.

Authors:  Nan Cao; Zumei Liu; Zhongyan Chen; Jia Wang; Taotao Chen; Xiaoyang Zhao; Yu Ma; Lianju Qin; Jiuhong Kang; Bin Wei; Liu Wang; Ying Jin; Huang-Tian Yang
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

2.  Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling.

Authors:  Joshua E Babiarz; Morgane Ravon; Sriram Sridhar; Palanikumar Ravindran; Brad Swanson; Hans Bitter; Thomas Weiser; Eric Chiao; Ulrich Certa; Kyle L Kolaja
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

3.  NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes.

Authors:  David A Elliott; Stefan R Braam; Katerina Koutsis; Elizabeth S Ng; Robert Jenny; Ebba L Lagerqvist; Christine Biben; Tanya Hatzistavrou; Claire E Hirst; Qing C Yu; Rhys J P Skelton; Dorien Ward-van Oostwaard; Sue Mei Lim; Ouda Khammy; Xueling Li; Susan M Hawes; Richard P Davis; Adam L Goulburn; Robert Passier; Owen W J Prall; John M Haynes; Colin W Pouton; David M Kaye; Christine L Mummery; Andrew G Elefanty; Edouard G Stanley
Journal:  Nat Methods       Date:  2011-10-23       Impact factor: 28.547

4.  Methods of cell purification: a critical juncture for laboratory research and translational science.

Authors:  Peter J Amos; Esra Cagavi Bozkulak; Yibing Qyang
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

Review 5.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

6.  A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation.

Authors:  George Kensah; Ina Gruh; Jörg Viering; Henning Schumann; Julia Dahlmann; Heiko Meyer; David Skvorc; Antonia Bär; Payam Akhyari; Alexander Heisterkamp; Axel Haverich; Ulrich Martin
Journal:  Tissue Eng Part C Methods       Date:  2011-01-14       Impact factor: 3.056

7.  Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA.

Authors:  Kiwon Ban; Brian Wile; Sangsung Kim; Hun-Jun Park; Jaemin Byun; Kyu-Won Cho; Talib Saafir; Ming-Ke Song; Shan Ping Yu; Mary Wagner; Gang Bao; Young-Sup Yoon
Journal:  Circulation       Date:  2013-08-30       Impact factor: 29.690

Review 8.  Eat, breathe, ROS: controlling stem cell fate through metabolism.

Authors:  Dieter A Kubli; Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-04-21

Review 9.  Heart regeneration with engineered myocardial tissue.

Authors:  Kareen L K Coulombe; Vivek K Bajpai; Stelios T Andreadis; Charles E Murry
Journal:  Annu Rev Biomed Eng       Date:  2014-04-24       Impact factor: 9.590

10.  Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.

Authors:  Alexandra Bizy; Guadalupe Guerrero-Serna; Bin Hu; Daniela Ponce-Balbuena; B Cicero Willis; Manuel Zarzoso; Rafael J Ramirez; Michelle F Sener; Lakshmi V Mundada; Matthew Klos; Eric J Devaney; Karen L Vikstrom; Todd J Herron; José Jalife
Journal:  Stem Cell Res       Date:  2013-09-18       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.